Market Overview:
The global pleurisy market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of pleurisy, rising awareness about the disease, and technological advancements in diagnostics and treatment options. The global pleurisy market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into antibiotics, antifungals, blood thinners (anticoagulants), and other drugs. The antibiotics segment accounted for a major share of the global pleurisy market in 2017 owing to their high usage for treating various types of infections including pneumonia and tuberculosis. However, with increasing resistance against antibiotics by microorganisms such as bacteria and fungi globally; there is an increased demand for novel drugs such as antifungals which are effective against resistant strains. On account of this trend; Antifungal drug manufacturers are focusing on developing novel products with better efficacy profiles that can cater to this growing demand from patients across regions worldwide thereby driving growth in this segment over the forecast period from 2018-2030 .
Product Definition:
Pleurisy is a condition that results when the pleura, the thin membrane that lines the chest and lungs, becomes inflamed.
Antibiotics:
Antibiotics Market is expected to grow at a CAGR of XX% during the forecast period. Increasing incidences of bacterial infections, especially in the lungs are anticipated to drive growth. According to CDC, about 2 million people develop bronchitis and pneumonia every year in U.S., which may lead to pleurisy or even death if not treated with antibiotics.
Antifungals:
Antifungals are medicines used to treat fungal infections. The most common types of fungal infections include athlete's foot, ringworm, and jock itch. Antifungal medications can be creams or oral drugs that are taken by mouth or applied to the skin. They work by killing the fungi that cause infection.
Application Insights:
Based on the application, the global pleurisy market is segmented into hospital, clinics and diagnostics laboratories. The hospital segment dominated the market in 2017 owing to a large patient base that requires treatment for various diseases related to Pleurisy. Hospital based Pleurisy treatment is more cost-effective as compared to outpatient treatments due Pleuritis Inflammation & Pain Syndrome (PIPS) cases occurring almost every year across globe which demands high medical expenditure for its treatment.
The clinics segment is expected to grow at a lucrative rate during forecast period owing to rising awareness regarding early diagnosis of PIPS among patients with symptoms such as shortness of breath and severe pain in chest wall region along with other signs such as feverishness and fatigue. Thus, increasing number of patients visiting hospitals or primary healthcare centers seeking advice from doctors regarding early diagnosis are expected drive growth over next few years.
Regional Analysis:
Europe dominated the global market in terms of revenue share in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing awareness levels among patients are some factors responsible for its large share. In addition, rising prevalence of pleurisy is also expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving economic conditions and growing medical tourism industry in emerging countries such as China and India. Moreover, an increase in per capita income has led to a rise in consumer spending on health care services which will further boost demand for pleurisy treatment drugs during the forecast period.
Growth Factors:
- Increasing incidence of respiratory diseases and disorders such as pleurisy, which is characterized by inflammation of the pleura and chest pain.
- Growing awareness about the symptoms and treatment options for pleurisy among patients and healthcare professionals.
- Rising demand for effective therapies for treating pleurisy, especially in developed countries with high healthcare expenditure levels.
- Technological advancements in the diagnosis and treatment of respiratory diseases that are helping to improve patient outcomes.
- increasing prevalence of smoking and other risk factors that contribute to the development of respiratory diseases
Scope Of The Report
Report Attributes
Report Details
Report Title
Pleurisy Market Research Report
By Type
Antibiotics, Antifungals, Blood Thinners
By Application
Hospital, Clinics, Diagnostics Laboratories
By Companies
Scanlan, Sontec Instruments, Pilling Surgical, Integra LifeSciences, Olympus Corporation, Delacroix-Chevalier, Myra, Wexler Surgical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
131
Number of Tables & Figures
92
Customization Available
Yes, the report can be customized as per your need.
Global Pleurisy Market Report Segments:
The global Pleurisy market is segmented on the basis of:
Types
Antibiotics, Antifungals, Blood Thinners
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Diagnostics Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Scanlan
- Sontec Instruments
- Pilling Surgical
- Integra LifeSciences
- Olympus Corporation
- Delacroix-Chevalier
- Myra
- Wexler Surgical
Highlights of The Pleurisy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Antifungals
- Blood Thinners
- By Application:
- Hospital
- Clinics
- Diagnostics Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pleurisy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pleurisy is an inflammation of the pleura, the thin membrane that covers the lungs. Pleurisy most often occurs in people over age 50 and is caused by a variety of factors, including infection, exposure to pollutants or allergens, or surgery. Symptoms may include chest pain, shortness of breath, coughing up blood (hemoptysis), and fever. Treatment typically includes antibiotics and rest.
Some of the key players operating in the pleurisy market are Scanlan, Sontec Instruments, Pilling Surgical, Integra LifeSciences, Olympus Corporation, Delacroix-Chevalier, Myra, Wexler Surgical.
The pleurisy market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pleurisy Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pleurisy Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pleurisy Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pleurisy Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pleurisy Market Size & Forecast, 2018-2028
4.5.1 Pleurisy Market Size and Y-o-Y Growth
4.5.2 Pleurisy Market Absolute $ Opportunity
Chapter 5 Global Pleurisy Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pleurisy Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Antifungals
5.2.3 Blood Thinners
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pleurisy Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pleurisy Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Diagnostics Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pleurisy Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pleurisy Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pleurisy Analysis and Forecast
9.1 Introduction
9.2 North America Pleurisy Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pleurisy Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Antifungals
9.6.3 Blood Thinners
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pleurisy Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Diagnostics Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pleurisy Analysis and Forecast
10.1 Introduction
10.2 Europe Pleurisy Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pleurisy Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Antifungals
10.6.3 Blood Thinners
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pleurisy Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Diagnostics Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pleurisy Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pleurisy Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pleurisy Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Antifungals
11.6.3 Blood Thinners
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pleurisy Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Diagnostics Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pleurisy Analysis and Forecast
12.1 Introduction
12.2 Latin America Pleurisy Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pleurisy Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Antifungals
12.6.3 Blood Thinners
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pleurisy Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Diagnostics Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pleurisy Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pleurisy Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pleurisy Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Antifungals
13.6.3 Blood Thinners
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pleurisy Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Diagnostics Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pleurisy Market: Competitive Dashboard
14.2 Global Pleurisy Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Scanlan
14.3.2 Sontec Instruments
14.3.3 Pilling Surgical
14.3.4 Integra LifeSciences
14.3.5 Olympus Corporation
14.3.6 Delacroix-Chevalier
14.3.7 Myra
14.3.8 Wexler Surgical
